What Researchers Did
Researchers retrospectively analyzed the clinical application of hyperbaric oxygen therapy over a 12-year period, treating 1288 patients for various conditions.
What They Found
The study reported high effective rates for hyperbaric oxygen therapy, including 97.5% for decompression sickness and 96.3% for chronic osteomyelitis. A modified treatment table for serious decompression sickness significantly increased the cure rate from 25.8% to 50.0% and reduced recurrence from 16.1% to 4.1% (P less than 0.05). Additionally, HBO therapy reduced mortality in burn patients from 14.8% to 6.8% (P less than 0.05).
What This Means for Canadian Patients
Hyperbaric oxygen therapy could offer a beneficial treatment option for Canadian patients suffering from conditions like decompression sickness, chronic wounds, and severe burns, potentially improving recovery and survival rates. Patients should discuss with their healthcare providers whether HBO therapy is appropriate for their specific condition.
Canadian Relevance
This study was conducted in a non-Canadian setting, therefore its direct relevance to the Canadian healthcare system and patient population is not explicitly established.
Study Limitations
The study is a retrospective report of clinical experience, which may be subject to selection bias and lacks randomized controlled trials for all reported conditions.